Antiphospholipid Syndrome: Intraoperative and Postoperative Anticoagulation in Cardiac Surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 22, Issue 5, 2008, Pages 735-739

  Weiss, Stuart ^a   Nyzio, Joseph B ^a   Cines, Douglas ^a   Detre, John ^a   Milas, Bonnie L ^a   Narula, Navneet ^a   Floyd, Thomas F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

antiphospholipid; cardiopulmonary bypass; endocarditis; hypercoagulable; Libman Sachs; lupus anticoagulant; stroke; thrombosis

Indexed keywords

AMFEBUTAMONE; ENOXAPARIN; FENTANYL; FLUOXETINE; HEPARIN; ISOFLURANE; METOPROLOL; MIDAZOLAM; PANCURONIUM; WARFARIN;

ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; DEPRESSION; DIZZINESS; DRUG WITHDRAWAL; ENDOCARDITIS; FEMALE; HEART SURGERY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRAOPERATIVE PERIOD; LIBMAN SACKS ENDOCARDITIS; MIGRAINE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; STROKE; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ULTRASOUND;

ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION TESTS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; MITRAL VALVE;

EID: 52149100785     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2008.01.021     Document Type: Article

References (31)

1. Wilson W.A., Gharavi A.E., Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 42 (1999) 1309-1311
2. Tenedios F., Erkan D., and Lockshin M.D. Cardiac involvement in the antiphospholipid syndrome. Lupus 14 (2005) 691-696
3. Ciocca R.G., Choi J., and Graham A.M. Antiphospholipid antibodies lead to increased risk in cardiovascular surgery. Am J Surg 170 (1995) 198-200
4. Hegde V.A., Vivas Y., Shah H., et al. Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome-a case series. Heart Lung Circ 16 (2007) 423-427
5. Rand J.H., Wu X.X., Andree H.A., et al. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: A "lupus procoagulant" phenomenon. Blood 92 (1998) 1652-1660
6. Galli M., Ruggeri L., and Barbui T. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C. Blood 91 (1998) 1999-2004
7. Warkentin T.E., Aird W.C., and Rand J.H. Platelet-endothelial interactions: Sepsis, HIT, and antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program (2003) 497-519
8. Ma K., Simantov R., Zhang J.C., et al. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem 275 (2000) 15541-15548
9. Bidot C.J., Jy W., Horstman L.L., et al. Factor VII/VIIa: A new antigen in the anti-phospholipid antibody syndrome. Br J Haematol 120 (2003) 618-626
10. Levine J.S., Branch D.W., and Rauch J. The antiphospholipid syndrome. N Engl J Med 346 (2002) 752-763
11. Mackworth-Young C.G. Antiphospholipid syndrome: Multiple mechanisms. Clin Exp Immunol 136 (2004) 393-401
12. Meroni P.L., Borghi M.O., Raschi E., et al. Inflammatory response and the endothelium. Thromb Res 114 (2004) 329-334
13. Erdogan D., Goren M.T., Diz-Kucukkaya R., et al. Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: A transesophageal echocardiographic study. Stroke 36 (2005) 592-596
14. Jara L.J., Medina G., Vera-Lastra O., et al. Atherosclerosis and antiphospholipid syndrome. Clin Rev Allergy Immunol 25 (2003) 79-88
15. Erkan D., Yazici Y., Sobel R., et al. Primary antiphospholipid syndrome: Functional outcome after 10 years. J Rheumatol 27 (2000) 2817-2821
16. Espinola-Zavaleta N., Vargas-Barron J., Colmenares-Galvis T., et al. Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Am Heart J 137 (1999) 973-978
17. Zavaleta N.E., Montes R.M., Soto M.E., et al. Primary antiphospholipid syndrome: A 5-year transesophageal echocardiographic followup study. J Rheumatol 31 (2004) 2402-2407
18. Sheikh F., Lechowicz A., Setlur R., et al. Recognition and management of patients with antiphospholipid antibody syndrome undergoing cardiac surgery. J Cardiothorac Vasc Anesth 11 (1997) 764-766
19. Ducart A.R., Collard E.L., Osselaer J.C., et al. Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant. J Cardiothorac Vasc Anesth 11 (1997) 878-879
20. Hogan W.J., McBane R.D., Santrach P.J., et al. Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery. Mayo Clin Proc 75 (2000) 971-976
21. East C.J., Clements F., Mathew J., et al. Antiphospholipid syndrome and cardiac surgery: Management of anticoagulation in two patients. Anesth Analg 90 (2000) 1098-1101
22. Leissner K.B., Ketchedjian A., Crowley R., et al. Deep hypothermic circulatory arrest and bivalirudin use in a patient with heparin-induced thrombocytopenia and antiphospholipid syndrome. J Card Surg 22 (2007) 78-82
23. Alpert D., Mandl L.A., Erkan D., et al. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Ann Rheum Dis 67 (2008) 395-401
24. Salmi L., Elalamy I., Leroy-Matheron C., et al. Thrombosis of a cardiopulmonary bypass circuit despite recommended hypocoagulation with danaparoid during the acute phase of type II heparin-induced thrombocytopenia. Ann Fr Anesth Reanim 25 (2006) 1144-1148
25. Fiedler K., and Wurfel W. Effectivity of heparin in assisted reproduction. Eur J Med Res 9 (2004) 207-214
26. Triolo G., Ferrante A., Ciccia F., et al. Randomized study of subcutaneous low-molecular-weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 48 (2003) 728-731
27. Lapchak P.A. Hemorrhagic transformation following ischemic stroke: Significance, causes, and relationship to therapy and treatment. Curr Neurol Neurosci Rep 2 (2002) 38-43
28. Crowther M.A., Ginsberg J.S., Julian J., et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 349 (2003) 1133-1138
29. Ferrara D.E., Swerlick R., Casper K., et al. Fluvastatin inhibits upregulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost 2 (2004) 1558-1563
30. Dunoyer-Geindre S., Kwak B.R., Pelli G., et al. Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques. Thromb Haemost 97 (2007) 129-138
31. Lockshin M.D., and Erkan D. Treatment of the antiphospholipid syndrome. N Engl J Med 349 (2003) 1177-1179